Teneligliptin Tablets

Form: Tablets

Strength: 20 mg, 40mg

Reference Brands: Tenelia®, Teneza®, and Teneliget®(India & Japan/ Asia)

Category: Diabetes

Teneligliptin, a DPP-4 inhibitor used for type 2 diabetes, is not approved by the U.S. FDA or the European Medicines Agency (EMA). It is currently not available in the US or EU markets due to the absence of regulatory submissions or market authorization. Teneligliptin is, however, widely approved in Asian countries like Japan and India. For companies seeking to register or introduce Teneligliptin in regulated markets, thorough clinical data, CTD dossiers, and compliance with ICH guidelines are essential. For regulatory consulting, dossier preparation, or global sourcing, visit PharmaTradz.com.